Medicare Enrolled
Dr. Scott Huang, DO
Family Medicine · San Francisco, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Huang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Huang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Huang
Dr. Scott Huang is a family medicine specialist in San Francisco, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Huang performed 744 Medicare services across 674 unique beneficiaries.
Between the years covered by Open Payments, Dr. Huang received a total of $20,954 from 47 pharmaceutical and/or device companies across 546 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Huang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 30% volume in CA
$20,954 industry payments
Medicare Practice Summary
Medicare Utilization ↗744
Medicare services
Top 30% in CA for family medicine
674
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~39 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
111 | $101 | $227 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
93 | $50 | $230 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
70 | $37 | $63 |
| COVID-19 vaccine (Moderna bivalent) An intramuscular injection of the SARS-CoV-2 vaccine containing 50 micrograms in a 0.5 mL dose. |
66 | $143 | $524 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $65 | $163 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
54 | $22 | $50 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
54 | $23 | $88 |
| Adm sarscv2 bvl 50mcg/.5ml a | 40 | $50 | $120 |
| SARS-CoV-2 vaccine, 50 mcg/0.5 mL Administration of a SARS-CoV-2 vaccine containing 50 micrograms of antigen in a 0.5 milliliter dose. |
40 | $0 | $0 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
34 | $91 | $188 |
| COVID-19 vaccine (Pfizer bivalent) Administration of a 30 mcg dose of the SARS-CoV-2 vaccine via intramuscular injection. |
27 | $128 | $445 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
27 | $157 | $393 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
16 | $72 | $172 |
| Annual alcohol misuse screening, 5 to 15 minutes | 16 | $24 | $50 |
| Annual depression screening | 15 | $24 | $50 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
14 | $37 | $63 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
11 | $281 | $480 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,954
Total received (2018-2024)
Avg $2,993/year across 7 years
Top 1% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
546
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,954 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,013
2023
$3,710
2022
$2,955
2021
$1,923
2020
$1,263
2019
$3,495
2018
$2,594
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$710
Novo Nordisk Inc
$502
AstraZeneca Pharmaceuticals LP
$375
Bayer Healthcare Pharmaceuticals Inc.
$367
ViiV Healthcare Company
$345
GlaxoSmithKline, LLC.
$310
Gilead Sciences, Inc.
$247
CALLIDITAS THERAPEUTICS US INC.
$221
E.R. Squibb & Sons, L.L.C.
$220
Agios Pharmaceuticals, Inc.
$197
Dynavax Technologies Corporation
$191
Stryker Corporation
$173
SCILEX PHARMACEUTICALS INC.
$147
Teva Pharmaceuticals USA, Inc.
$137
Janssen Pharmaceuticals, Inc
$129
Lilly USA, LLC
$121
Lexicon Pharmaceuticals, Inc.
$114
Merck Sharp & Dohme LLC
$90
Edwards Lifesciences Corporation
$88
Boehringer Ingelheim Pharmaceuticals, Inc.
$87
Xeris Pharmaceuticals, Inc.
$66
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$64
Dexcom, Inc.
$48
Vifor Pharma, Inc.
$22
Mallinckrodt Hospital Products Inc.
$22
Astellas Pharma US Inc
$20
Top 3 companies account for 31.6% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$3,214
AstraZeneca Pharmaceuticals LP
$1,973
Amgen Inc.
$1,792
GlaxoSmithKline, LLC.
$1,586
Janssen Pharmaceuticals, Inc
$1,235
Novo Nordisk Inc
$1,190
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,145
Lilly USA, LLC
$929
ViiV Healthcare Company
$891
Bayer Healthcare Pharmaceuticals Inc.
$780
E.R. Squibb & Sons, L.L.C.
$725
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$506
Merck Sharp & Dohme Corporation
$453
PFIZER INC.
$392
Dynavax Technologies Corporation
$383
Shire North American Group Inc
$259
Scilex Pharmaceuticals Inc.
$257
AbbVie, Inc.
$244
Horizon Therapeutics plc
$236
Mallinckrodt Hospital Products Inc.
$225
CALLIDITAS THERAPEUTICS US INC.
$221
Merck Sharp & Dohme LLC
$198
Agios Pharmaceuticals, Inc.
$197
Stryker Corporation
$173
Relypsa, Inc.
$171
CeQur Corporation
$148
SCILEX PHARMACEUTICALS INC.
$147
Astellas Pharma US Inc
$145
Teva Pharmaceuticals USA, Inc.
$137
Amarin Pharma Inc.
$128
Regeneron Healthcare Solutions, Inc.
$120
Lexicon Pharmaceuticals, Inc.
$114
Janssen Biotech, Inc.
$110
Xeris Pharmaceuticals, Inc.
$103
Edwards Lifesciences Corporation
$88
Mannkind Corporation
$50
Otsuka America Pharmaceutical, Inc.
$48
Dexcom, Inc.
$48
Calliditas Therapeutics US Inc.
$32
Exact Sciences Corporation
$28
Bayer HealthCare Pharmaceuticals Inc.
$26
Biohaven Pharmaceutical Holding Company Ltd.
$23
Vifor Pharma, Inc.
$22
Ultragenyx Pharmaceutical Inc.
$18
Phadia US Inc.
$15
QIAGEN SCIENCES LLC
$15
Sanofi Pasteur Inc.
$14
Top 3 companies account for 33.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADVATE · AFREZZA · APRETUDE · AREXVY · Aimovig · Austedo XR · BAQSIMI · BEXSERO · BREATHTEK · BREZTRI · BYDUREON · CAMZYOS · CeQur Simplicity · Cologuard Collection Kit · Crysvita · Descovy · Dexcom G6 Transmitter · ELIQUIS · ELYXYB - CELECOXIB · EMGALITY · EVENITY · FARXIGA · FASENRA · FLUARIX · FLUZONE HIGH-DOSE · GARDASIL · GARDASIL 9 · GLYXAMBI · GVOKE HYPOPEN · Heplisav-B · INVOKANA · ImmunoCAP · Inpefa · JANUVIA · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · MDx Quantiferon · MOUNJARO · NURTEC ODT · OFEV · OMNICURVE · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PYRUKYND · Prolia · REBLOZYL · RYBELSUS · RYBREVANT · Rybelsus · SAPIEN 3 Ultra RESILIA · SHINGRIX · STEGLATRO · STIOLTO RESPIMAT · Saxenda · TARPEYO · TAVNEOS · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Truvada · VARIVAX · Vascepa · Veltassa · Vemlidy · Venclexta · Veozah · Wegovy · XARELTO · XIFAXAN · XTANDI · ZOSTAVAX · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
1,442
Per 100K population
172.4
County median income
$141,446
Nearest hospital
JEWISH HOME & REHAB CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Huang is a clinical cardiology specialist, with above-average Medicare volume (top 30% in CA), with low-engagement industry engagement in the top 1% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Huang experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Huang performed 111 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Huang receive payments from pharmaceutical companies?
Yes. Dr. Huang received a total of $20,954 from 47 companies across 546 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Huang's costs compare to other family medicine physicians in San Francisco?
Dr. Huang's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Huang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in San Francisco
Browse family medicine physicians in San Francisco ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology